Newsletter | April 11, 2025

04.11.25 -- Oral Therapies Take Center Stage For PsO And PsA Treatment

SPONSOR

Webinar: 3D Screen Printing: Breakthrough Solutions for Patient-Centric Therapies

This webinar explores 3D screen printing in pharmaceutical manufacturing, a breakthrough overcoming scalability and formulation challenges of traditional 3D printing. It enables precise layering for multi-functional tablets with customizable drug release profiles, enhancing efficacy and patient convenience. Attendees will learn how this cost-effective, scalable technology optimizes pharmacokinetics, reduces API use, and offers new IP opportunities. Click here to learn more.

INDUSTRY INSIGHTS

Navigating The Small Molecule CMC Pathway

Advancing a small molecule candidate from discovery to clinic is a complicated journey. Learn more about the factors that can accelerate timelines and help improve downstream clinical outcomes.

The Complexities Of Early Phase Ophthalmic Drug Development

Discover how the complexity and challenges of bringing ophthalmic therapeutics to market can be mitigated by entrusting your drug development program to an integrated CRO/CDMO partner.

The Importance Of Flexibility In HPAPI Small-Batch Manufacturing

Watch as experts provide insight into the challenges of HPAPI manufacturing and offer proven strategies for achieving the flexibility required for small-batch production.

FEATURED EDITORIAL

Oral Therapies Take Center Stage For PsO And PsA Treatment

The recent American Academy of Dermatology 2025 Annual Meeting in early March featured major updates on efficacy and safety for two key oral therapies in autoimmune diseases.

Training Specifically For Tech Transfer Skills Does Exist

Professionals in our development and manufacturing outsourcing ecosystem are concerned about inadequate training — both in-house at biotechs and at CDMOs — highlighting a shortage of skilled personnel needed for efficient technology transfers.

INDUSTRY INSIGHTS CONTINUED

Spray Drying For Innovative Dry Powder Inhaler Combination Formulations

Combination therapies delivered directly to the lung by dry powder inhalants are an effective means of reducing patient burden. Read about case studies that illustrate the potential for improving care.

Small Scale, Big Impact: The Advantages Of Flexible Pilot Plant Equipment

Consider the benefits of flexible pilot plant equipment, such as being able to seamlessly scale up your processes, optimize your formulations, and save costs with in-house small-volume production.

SOLUTIONS

Development And Manufacturing Services

Take advantage of our differentiated pharmaceutical technology and microbiome scientific platforms to develop novel, improved medicines and therapies for the global market.

This Is Your Team At Cambrex

We’re committed to helping our customers succeed and tackling challenges of any size. Meet the team of experts you’ll love collaborating with.

Bottling Solutions

This bottling solution is meticulously engineered to adhere to the most stringent pharmaceutical standards, guaranteeing that each product is crafted with unparalleled quality and precision.

OUTSOURCED PHARMA CAPACITY UPDATE

Find Your New CDMO At Outsourced Pharma Capacity Update

CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs.

Connect With Outsourced Pharma: